Cargando…

BIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging

Bridging integrator 1 (BIN1) has been implicated in sporadic Alzheimer’s disease (AD) by a number of genome wide association studies (GWAS) in a variety of populations. Here we measured BIN1 in frontal cortex samples from 24 sporadic AD and 24 age-matched non-dementia brains and correlated the expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glennon, Elizabeth B. C., Whitehouse, Isobel J., Miners, J. Scott, Kehoe, Patrick G., Love, Seth, Kellett, Katherine A. B., Hooper, Nigel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804620/ https://www.ncbi.nlm.nih.gov/pubmed/24205320 http://dx.doi.org/10.1371/journal.pone.0078806

Ejemplares similares

Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage
por: Whitehouse, Isobel J., et al.
Publicado: (2013)

Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
por: Rowland, Helen A., et al.
Publicado: (2018)

The Role of Zinc in Alzheimer's Disease
por: Watt, Nicole T., et al.
Publicado: (2010)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

Plasma metals as potential biomarkers in dementia: a case–control study in patients with sporadic Alzheimer’s disease
por: Xu, Jingshu, et al.
Publicado: (2018)

Cognitive impact of COVID-19: looking beyond the short term
por: Miners, Scott, et al.
Publicado: (2020)

Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease
por: Miners, J. Scott, et al.
Publicado: (2015)

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
por: Fisher, Robert A., et al.
Publicado: (2022)

Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype
por: Whitehouse, Isobel J., et al.
Publicado: (2016)

Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease
por: Miners, J Scott, et al.
Publicado: (2017)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer’s Disease
por: MacLachlan, Robert, et al.
Publicado: (2022)

Cellular Prion Protein Expression Is Not Regulated by the Alzheimer's Amyloid Precursor Protein Intracellular Domain
por: Lewis, Victoria, et al.
Publicado: (2012)

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology
por: Miners, J. S., et al.
Publicado: (2019)

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer’s disease
por: AL Mulhim, Noura S., et al.
Publicado: (2019)

Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia
por: Tayler, Hannah, et al.
Publicado: (2021)

A Unifying Hypothesis for Familial and Sporadic Alzheimer's Disease
por: Proctor, Carole J., et al.
Publicado: (2012)

Glypican-1 Mediates Both Prion Protein Lipid Raft Association and Disease Isoform Formation
por: Taylor, David R., et al.
Publicado: (2009)

Activators and inhibitors of the plasminogen system in Alzheimer’s disease
por: Barker, Rachel, et al.
Publicado: (2012)

Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease
por: Hadjidemetriou, Marilena, et al.
Publicado: (2021)

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease
por: MacLachlan, Robert, et al.
Publicado: (2022)

3D hydrogel models of the neurovascular unit to investigate blood–brain barrier dysfunction
por: Potjewyd, Geoffrey, et al.
Publicado: (2021)

Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes
por: Miners, J. Scott, et al.
Publicado: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado: (2016)

Influence of the bin to bin and inside bin correlations on measured quantities
por: Perevoztchikov, V, et al.
Publicado: (1999)

Influence of the bin-to-bin and inside bin correlations on measured quantities
por: Perevozchikov, V, et al.
Publicado: (2000)

Pericyte Contractile Responses to Endothelin-1 and Aβ Peptides: Assessment by Electrical Impedance Assay
por: Hibbs, Elliott, et al.
Publicado: (2021)

Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease
por: Lu, Kirsty, et al.
Publicado: (2021)

Prominent and conspicuous astrocyte atrophy in human sporadic and familial Alzheimer’s disease
por: Rodríguez, J. J., et al.
Publicado: (2023)

PhyBin: binning trees by topology
por: Newton, Ryan R., et al.
Publicado: (2013)

Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease
por: Kalaria, Rajesh N., et al.
Publicado: (2021)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
por: Twohig, Daniel, et al.
Publicado: (2018)

Protocol for refining metagenomic binning with BinSPreader
por: Ochkalova, Sofia, et al.
Publicado: (2023)

Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers
por: Quinn, James P., et al.
Publicado: (2018)

Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
por: Chapuis, J, et al.
Publicado: (2013)

Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1
por: Miners, J Scott, et al.
Publicado: (2014)

Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
por: Israel, Mason A., et al.
Publicado: (2012)

Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer’s disease
por: Condello, Carlo, et al.
Publicado: (2018)

The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer's Disease
por: Van Dooren, Tom, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7vjnrsur0vict3m1oair7108jl